○Yuming Qiao^1,3, Yuki Kida^2,3, Nobuko Koshikawa¹, Keizo Takenaga¹ (1. Div. Cancer Genetics., Chiba Cancer Center Res. Inst., 2. Div. Innov. Cancer Therap., Chiba Cancer Center Res. Inst., 3. Grad. Sch. Med. Pharm. Sci., Chiba Univ.)

○Kaoruko Hayashi¹, Atsushi Koike¹, Ko Fujimori¹ (1. Pharm. Sci., Osaka Med. Pharm. Univ.)

○Yuta Semba¹, Shunsuke Takahashi¹, Takahisa Shinomiya¹, Yukitoshi Nagahara¹ (1. Dept. of Sci. Eng., Tokyo Denki Univ.)

○Takeo Tatsuta¹, Arisu Nakasato¹, Yoshito Sato¹, Shigeki Sugawara¹, Masahiro Hosono¹ (1. Division of Cell Recognition, Tohoku Medical and Pharmaceutical University)

Mikana Suzuki¹, ○Satoru Asami², Toshimitsu Nakayama³, Yasuyo Shimoda², Koichi Kato², Kenzo Yamanaka², Takahiro Matsumoto¹, Kenji Nishizawa¹, Takashi Suzuki² (1. Toho University Omori Medical Center, 2. Nihon University School of Pharmacy, 3. Nihon University Itabashi Hospital)

○Ai Kobayashi¹, Kazunori Hashimoto¹, Tomiyasu Murata¹ (1. Meijo Univ.)

○Kenji Takeuchi¹, Chisako Tagawa¹, Daigo Nishitani¹, Shota Mori¹, Ryuji Yamazawa¹, Kiyoshi Ito¹ (1. Fac. Pharm. Sci., Setsunan Univ.)

○Takehiro Ohara¹, Takashige Kawakami¹, Tomomi Abe¹, Kojun Setsu¹, Masahisa Inoue¹ (1. Faculty Of Pharmaceutical Sciences Tokushima Bunri University)

○Rie Sasaki¹, Mai Ebisu¹, Ryoko Takasawa¹ (1. Facul. Pharm. Sci., Tokyo Univ. Sci.)

○Minori Kimura¹, Kohtaro Sasaki¹, Ryoko Takasawa¹ (1. Facul. Pharm. Sci., Tokyo Univ. Sci. )